In 2024, business enterprise R&D expenditure in the manufacture of medical and dental instruments and supplies in the US is anticipated to be $22.3 billion, up from the actual expenditure in 2023. Forecasts indicate a consistent year-on-year increase of approximately 6%, reaching $27.34 billion by 2028. Over the five-year period, the compound annual growth rate (CAGR) is around 5.1%, reflecting robust sector investment. This trend suggests strong ongoing commitment to innovation and development in medical technology.
Future trends to watch for include technological advancements in medical devices, regulatory changes, and shifts in healthcare demands. These factors could significantly impact R&D spending patterns and strategic focus within the industry.
